Skip to main content
Clinical Trials/NCT00935870
NCT00935870
Completed
Not Applicable

Bioactive Glass (S53P4) as Bone Graft Substitute in Operative Treatment of Depressed Lateral Condyle Fractures, Benign Bone Tumour Cavities and in Spinal Fusion - a 10 Years Follow-up and Bone Density Study.

Vivoxid Ltd1 site in 1 country63 target enrollmentJanuary 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Depressed Lateral Condyle Fracture
Sponsor
Vivoxid Ltd
Enrollment
63
Locations
1
Status
Completed
Last Updated
16 years ago

Overview

Brief Summary

The main aim is to evaluate the long-term safety and bone healing in the operated area and to compare bioactive glass granules with autogenous bone as a filler material.

Registry
clinicaltrials.gov
Start Date
January 2008
End Date
February 2009
Last Updated
16 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Vivoxid Ltd

Eligibility Criteria

Inclusion Criteria

  • Written informed consent obtained; Participation of previous clinical investigation with bioactive glass

Exclusion Criteria

  • The subject is unlikely to adhere to study procedures
  • Concurrent disease or condition that in the opinion of the investigator is contraindicating participation
  • Simultaneous participation in another medical device or investigational drug trial

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials